Michael I Jesson

Affiliations

Pfizer Global Research & Development, Cambridge, Massachusetts.

Publications (3)

Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in

American journal of physiology. Renal physiology

Avec: Gregory H Tesch , Nick Pullen , Franklin J Schlerman , David J Nikolic-Paterson

Janus kinase inhibitors for the treatment of rheumatoid arthritis demonstrate similar profiles of in vitro cytokine receptor inhibition.

Pharmacology research & perspectives

Avec: Martin E Dowty , Tsung H Lin , Martin Hegen , David A Martin , Vaibhav Katkade , Sujatha Menon , Jean-Baptiste Telliez

PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor.

ACS chemical biology

Avec: Hua Xu , Uthpala I Seneviratne , Tsung H Lin , M Nusrat Sharif , Liang Xue , Chuong Nguyen , Robert A Everley , John I Trujillo , Douglas S Johnson , Gary R Point , Atli Thorarensen , Iain Kilty , Jean-Baptiste Telliez

Réseau de co-auteurs

Tsung H Lin 2 collaborations

Jean-Baptiste Telliez 2 collaborations

Gregory H Tesch 1 collaboration

Nick Pullen 1 collaboration

Franklin J Schlerman 1 collaboration

David J Nikolic-Paterson 1 collaboration

Martin E Dowty 1 collaboration

Martin Hegen 1 collaboration

David A Martin 1 collaboration

Vaibhav Katkade 1 collaboration

Sujatha Menon 1 collaboration

Hua Xu 1 collaboration

Uthpala I Seneviratne 1 collaboration

M Nusrat Sharif 1 collaboration

Liang Xue 1 collaboration

Chuong Nguyen 1 collaboration

Robert A Everley 1 collaboration

John I Trujillo 1 collaboration

Douglas S Johnson 1 collaboration

Gary R Point 1 collaboration

Atli Thorarensen 1 collaboration

Iain Kilty 1 collaboration